Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,071,436
+$3,947,905 QoQ
Shares Held
566,009
+203.8% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. VIR ranks #56 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in VIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,071,436 | 566,009 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,123,531 | 186,324 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $868,707 | 152,138 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,261,975 | 448,805 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,738,562 | 268,297 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $89,987 | 12,260 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $126,745 | 16,922 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $133,829 | 15,037 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $263,976 | 26,059 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $206,159 | 20,493 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $842,128 | 89,875 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,122,432 | 290,356 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,857,627 | 337,672 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,812,513 | 308,673 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,800,692 | 352,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,341,288 | 209,709 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,818,140 | 109,570 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $413,352 | 9,498 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $620,930 | 12,111 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $739,571 | 21,543 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||